These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11348743)

  • 21. Management of severe burn injuries with topical heparin: the first evidence-based study in Ghana.
    Agbenorku P; Fugar S; Akpaloo J; Hoyte-Williams PE; Alhassan Z; Agyei F
    Int J Burns Trauma; 2013; 3(1):30-6. PubMed ID: 23386983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin-induced thrombocytopenia: how to manage it, how to avoid it.
    Caiola E
    Cleve Clin J Med; 2000 Sep; 67(9):621-4. PubMed ID: 10992619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chitosan and heparin on early extension of burns.
    Jin Y; Ling PX; He YL; Zhang TM
    Burns; 2007 Dec; 33(8):1027-31. PubMed ID: 17614208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulated neovascularization, inflammation resolution and collagen maturation in healing rat cutaneous wounds by a heparan sulfate glycosaminoglycan mimetic, OTR4120.
    Tong M; Tuk B; Hekking IM; Vermeij M; Barritault D; van Neck JW
    Wound Repair Regen; 2009; 17(6):840-52. PubMed ID: 19903305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA; Quinn CC; Wang W; Tromp G
    J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin/N-acetylcysteine: an adjuvant in the management of burn inhalation injury: a study of different doses.
    Elsharnouby NM; Eid HE; Abou Elezz NF; Aboelatta YA
    J Crit Care; 2014 Feb; 29(1):182.e1-4. PubMed ID: 23932140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Applications of Heparin and Other Glycosaminoglycans.
    Lima M; Rudd T; Yates E
    Molecules; 2017 May; 22(5):. PubMed ID: 28481236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of inhalable formulations of anti-inflammatory drugs to potentially treat smoke inhalation injury in burn victims.
    Thai A; Xiao J; Ammit AJ; Rohanizadeh R
    Int J Pharm; 2010 Apr; 389(1-2):41-52. PubMed ID: 20080165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
    Hallak LK; Collins PL; Knudson W; Peeples ME
    Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies in burns: XV. Use of a topical lipid in treating human burns.
    Jelenko C; McKinley JC
    Am Surg; 1976 Nov; 42(11):838-48. PubMed ID: 791038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin reduced mortality and sepsis in severely burned children.
    Zayas GJ; Bonilla AM; Saliba MJ
    Ann Burns Fire Disasters; 2007 Mar; 20(1):29-34. PubMed ID: 21991064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
    Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
    Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
    Ortel TL; Gockerman JP; Califf RM; McCann RL; O'Connor CM; Metzler DM; Greenberg CS
    Thromb Haemost; 1992 Mar; 67(3):292-6. PubMed ID: 1379384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of heparin in the local treatment of burns.
    Troshev K; Dimitrov R
    Acta Chir Plast; 2001; 43(4):143-4. PubMed ID: 11789055
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfated glycosaminoglycans inhibit hyaluronic acid synthesizing activity in mouse cumuli oophori.
    Eppig JJ; Ward-Bailey PF
    Exp Cell Res; 1984 Feb; 150(2):459-65. PubMed ID: 6319167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
    Bartholomew JR
    Chest; 2005 Feb; 127(2 Suppl):27S-34S. PubMed ID: 15706028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of topical application of 10,000 IU heparin on patients with perineal dermatitis and second-degree burns treated in a public pediatric hospital.
    Ferreira Chacon JM; Mello de Andrea ML; Blanes L; Ferreira LM
    J Tissue Viability; 2010 Nov; 19(4):150-8. PubMed ID: 20409713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical Erythropoietin Treatment Accelerates the Healing of Cutaneous Burn Wounds in Diabetic Pigs Through an Aquaporin-3-Dependent Mechanism.
    Hamed S; Ullmann Y; Egozi D; Keren A; Daod E; Anis O; Kabha H; Belokopytov M; Ashkar M; Shofti R; Zaretsky A; Schlesinger M; Teot L; Liu PY
    Diabetes; 2017 Aug; 66(8):2254-2265. PubMed ID: 28546424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.